Quest Diagnostics IncDGX
Price$231.09Intrinsic value$158.2632% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $11.6B+17.1% YoYTTM through 30 Jun 2026
Net Income $1.1B+21.9% YoYTTM through 30 Jun 2026
Free Cash Flow $1.3BTTM through 30 Jun 2026

Margins

Current
EBITDA Margin19.1%
Operating Margin13.8%
Net Margin9.2%

Returns

14.1%ROE
6.3%ROA
8.5%ROIC

Balance Sheet Health

Debt / Equity0.75x
Current Ratio1.18x
Net Debt$5.3B
Cash & Equivalents$626M

Quality Metrics

Altman Z-Score3.58
Piotroski F-Score7 / 9
FCF Margin11.7%
Rule of 4015.5
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $11B
Diluted EPS$9.42TTM
'19'20'21'22'23'24'25
FY2025: $8.75

Dividend

$2.52Per share, FY20261.07%Yield+0.8%5-yr growth

Capital Allocation

Capex Intensity4.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.